Description

On episode #29 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the weeks of 5/11 – 5/23/23.

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of Puscast!

Links for this episode

• Harmonie phase IIIb study trial results of nirsevimab against RSV lower respiratory tract infection hospitalization for infants (ESPID)
• Mogamulizumab for treatment of HTLV-1 associated Myelopathy/Tropical Spastic Paraparesis (IDSA)
• Revised protocol for secondary prevention of congenital cytomegalovirus infection with valaciclovir (IDSA)
• Increase in false positive fourth generation HIV tests in patients with COVID-19 (CID)
• Implementation of an antibiotic stewardship initiative in a large urgent care network (JAMA)
• Clindamycin + vancomycin versus linezolid for treatment of necrotizing soft tissue infection (OFID)
• Assessing empiric antimicrobial therapy with the dundee classification for skin and soft tissue infections (OFID)
• Combination of amoxicillin 3000mg and probenecid vs 1500mg amoxicillin monotherapy for treating syphilis in patients with HIV (CID)
• The sympathetic nervous system is necessary for development of CD4+ T cell memory following Staphylococcus aureus infection (JID)
• Efficacy and safety of sulbactam-durlobactam versus colistin for the treatment of patients with infections caused by Acinetobacter baumannii-calcoaceticu complex (The Lancet)
• First reported US cases of tinea caused by Trichophyton indotineae (CDC)
• How to use direct microscopy for diagnosing fungal infections (CMI)
• Limited Cutaneous Leishmaniasis as Ulcerated Verrucous Plaque on leg (EID)
• Can Ivermectin kill Sarcoptes scabiei during the molting process? (PLOS)
• The Infectious Diseases Specialist, at risk of extinction (JID)
• Ticks harbor and excrete chronic wasting disease prions (NIH)

Music is by Ronald Jenkees